Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll‐like receptor 3 activation

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Glia

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/glia.21125PMID 21319223PMCID PMC3082133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Key Role of CD36 in Toll-Like Receptor 2 Signaling in Cerebral Ischemia

  2010influential reference
• Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

  2010influential reference
• Pattern recognition receptors and inflammation.

  2010cited by this paper
• Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction.

  2010cited by this paper
• Elevated Ratio of Urinary Metabolites of Thromboxane and Prostacyclin Is Associated with Adverse Cardiovascular Events in ADAPT

  2010cited by this paper
• Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration

  2010cited by this paper
• Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation

  2009influential reference
• Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology.

  2009cited by this paper
• Tumour Necrosis Factor Modulation for Treatment of Alzheimer’s Disease

  2009cited by this paper
• Regulation of innate immune responses in the brain

  2009cited by this paper
• CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

  2009influential reference
• Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2.

  2009cited by this paper
• Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology

  2009cited by this paper
• beta-Glucan attenuates TLR2- and TLR4-mediated cytokine production by microglia.

  2009cited by this paper
• CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation

  2009influential reference
• Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE

  2009influential reference
• Protective effects of NSAIDs on the development of Alzheimer disease

  2008cited by this paper
• Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

  2008cited by this paper
• Toll-Like Receptor Prestimulation Increases Phagocytosis of Escherichia coli DH5α and Escherichia coli K1 Strains by Murine Microglial Cells

  2008cited by this paper
• Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease

  2008cited by this paper
• Fibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer’s Disease1

  2008influential reference
• Synuclein activates microglia in a model of Parkinson's disease.

  2008cited by this paper
• Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice.

  2008cited by this paper
• Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.

  2008influential reference
• Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration

  2008cited by this paper
• Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease

  2007cited by this paper
• Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo.

  2007cited by this paper
• Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

  2007cited by this paper
• Prevention of Alzheimer's disease

  2007cited by this paper
• Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.

  2007cited by this paper
• Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses.

  2007influential reference
• Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

  2007cited by this paper
• Involvement of Prostaglandin E2 in Production of Amyloid-β Peptides Both in Vitro and in Vivo*

  2007cited by this paper
• TLR3-Dependent Induction of Nitric Oxide Synthase in RAW 264.7 Macrophage-Like Cells via a Cytosolic Phospholipase A2/Cyclooxygenase-2 Pathway1

  2007influential reference
• Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein

  2007cited by this paper
• The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats.

  2007cited by this paper
• Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

  2007influential reference
• TLR3‐mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: Differential signaling mechanisms of TLR3‐induced IP‐10 and IL‐8 gene expression

  2006cited by this paper
• Alpha-synuclein expression modulates microglial activation phenotype.

  2006cited by this paper
• Trial of celecoxib in amyotrophic lateral sclerosis

  2006influential reference
• Science fraud: from patchwork mouse to patchwork data

  2006cited by this paper
• Blocking Soluble Tumor Necrosis Factor Signaling with Dominant-Negative Tumor Necrosis Factor Inhibitor Attenuates Loss of Dopaminergic Neurons in Models of Parkinson's Disease

  2006cited by this paper
• α-Synuclein Expression Modulates Microglial Activation Phenotype

  2006cited by this paper
• Comparative study of microglia activation induced by amyloid‐beta and prion peptides: Role in neurodegeneration

  2006cited by this paper
• Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity

  2006cited by this paper
• Toll-Like Receptor 2 Signaling in Response to Brain Injury: An Innate Bridge to Neuroinflammation

  2006influential reference
• Ibuprofen Suppresses Interleukin-1β Induction of Pro-Amyloidogenic α1-Antichymotrypsin to Ameliorate β-Amyloid (Aβ) Pathology in Alzheimer's Models

  2005cited by this paper
• [Prevention of Alzheimer's disease].

  2005cited by this paper
• TLR Signaling Tailors Innate Immune Responses in Human Microglia and Astrocytes1

  2005cited by this paper
• A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment

  2005influential reference
• Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice

  2005cited by this paper
• Inflammatory process in Parkinson's disease: role for cytokines.

  2005cited by this paper
• Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity

  2005cited by this paper
• Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.

  2005cited by this paper
• Clinical aspects of inflammation in Alzheimer's disease

  2005cited by this paper
• Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer’s disease

  2005cited by this paper
• Deletion of the Prostaglandin E2 EP2 Receptor Reduces Oxidative Damage and Amyloid Burden in a Model of Alzheimer's Disease

  2005cited by this paper
• mRNA Is an Endogenous Ligand for Toll-like Receptor 3*

  2004cited by this paper
• Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs1

  2004cited by this paper
• Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.

  2004cited by this paper
• Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatum

  2004cited by this paper
• Neuronal injury mediated via stimulation of microglial toll‐like receptor‐9 (TLR9)

  2004cited by this paper
• Induction of Cyclooxygenase-2 Overexpression in Human Gastric Epithelial Cells by Helicobacter pylori Involves TLR2/TLR9 and c-Src-Dependent Nuclear Factor-κB Activation

  2004influential reference
• Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway.

  2004cited by this paper
• Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

  2003cited by this paper
• Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

  2003influential reference
• Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

  2003cited by this paper
• Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS

  2002cited by this paper
• Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra.

  2002cited by this paper
• Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease

  2002cited by this paper
• Indomethacin protects against neurodegeneration caused by MPTP intoxication in mice.

  2002cited by this paper
• Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice.

  2001cited by this paper
• Inhibition of the cyclooxygenase isoenzymes COX‐1 and COX‐2 provide neuroprotection in the MPTP‐mouse model of Parkinson's disease

  2001cited by this paper
• Induction of cytokines in glial cells surrounding cortical β‐amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology

  2000cited by this paper
• Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease

  2000cited by this paper
• Inhibition of cyclooxygenase‐2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis

  2000cited by this paper
• TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs.

  1999cited by this paper
• TNFα plus IFNγ induce the production of Alzheimer β‐amyloid peptides and decrease the secretion of APPs

  1999cited by this paper
• Elevated CSF prostaglandin E2 levels in patients with probable AD.

  1999cited by this paper
• RNA sequestration to pathological lesions of neurodegenerative diseases

  1998influential reference
• Parkinson's disease: Neurodegenerative mechanisms and neuroprotective interventions—report of a workshop

  1998cited by this paper
• Aspirin and Salicylate Protect Against MPTP‐Induced Dopamine Depletion in Mice

  1998cited by this paper
• Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease

  1995cited by this paper

• Activation of EP2 receptor suppresses poly(I: C) and LPS‐mediated inflammation in primary microglia and organotypic hippocampal slice cultures: Contributing role for MAPKs

  2018cites this paper
• Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium

  2017cites this paper
• Upregulated TLR3 Promotes Neuropathic Pain by Regulating Autophagy in Rat With L5 Spinal Nerve Ligation Model

  2016cites this paper
• Poly(I:C) increases the expression of mPGES-1 and COX-2 in rat primary microglia

  2016cites this paper
• Different mechanisms of apolipoprotein E isoform‐dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia

  2015cites this paper
• Regulation of microglial cell function by corticosteroids and disruption by organotins

  2014cites this paper
• Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice

  2014cites this paper
• Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice.

  2014cites this paper
• P1‐098: PROSTAGLANDIN E2 RECEPTOR SUBTYPE 2 REGULATION OF SCAVENGER RECEPTOR CD36 MODULATES MICROGLIAL AB42 PHAGOCYTOSIS

  2014cites this paper
• Mathematical Analysis of ALS Biochemistry

  2014influential citation
• Inhibition of metabotropic glutamate receptor 5 induces cellular stress through pertussis toxin-sensitive Gi-proteins in murine BV-2 microglia cells

  2014cites this paper
• APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease.

  2013cites this paper
• Astrocytes inhibit nitric oxide‐dependent Ca2+ dynamics in activated microglia: Involvement of ATP released via pannexin 1 channels

  2013cites this paper
• Excitotoxicity-induced immediate surge in hippocampal prostanoid production has latent effects that promote chronic progressive neuronal death.

  2013cites this paper
• Eicosanoid receptor subtype‐mediated opposing regulation of TLR‐stimulated expression of astrocyte glial‐derived neurotrophic factor

  2012cites this paper
• Antagonism of Neuronal Prostaglandin E2 Receptor Subtype 1 Mitigates Amyloid β Neurotoxicity In Vitro

  2012cites this paper
• Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation

  2012cites this paper
• Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease.

  2011cites this paper